Back to Market Feed

Product Information

MESALAMINE ER 0.375 GRAM CAP is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.4865 per EA under NDC 00378137578. Its NADAC has been published 340 times since Feb 19, 2020.

FDA first approved this application on Nov 20, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

MESALAMINE ER 0.375 GRAM CAP

mesalamine
$0.4865per EA

Strength

.375 g/1

NDC

00378137578

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

MESALAMINE

Approval Type

Generic (ANDA)

FDA Application

ANDA207271

FDA Approved

11/20/2019

TE Code

AB

On Market Since

11/26/2019

Pharmacological Classes

Aminosalicylate
Aminosalicylic Acids

Price Statistics

The NADAC for MESALAMINE ER 0.375 GRAM CAP has been published 340 times since Feb 19, 2020, and over the history we have for it it has declined 83.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.4865 per EA
All-time high$3.1530 (Aug 12, 2020)
All-time low$0.4196 (Feb 18, 2026)
52-week high$0.4979
52-week low$0.4196
Median price$0.8904
Average price$1.2602
Largest weekly change-38.7% (Jul 17, 2024)
Weeks tracked340
Tracking sinceFeb 19, 2020

Price History

1W

+0.7%

1M

+0.7%

3M

-0.4%

6M

+15.9%

1Y

-1.0%

3Y

-38.7%

5Y

-75.5%

All

-83.5%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the mesalamine market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

MESALAMINE 4 GM/60 ML ENEMA
Generic
21922004547•Encube Ethicals, Inc.
$0.0974
per ML
MESALAMINE 4 GM/60 ML ENEMA
Generic
45802009851•Padagis Israel Pharmaceuticals Ltd
$0.0974
per ML
MESALAMINE 4 GM/60 ML ENEMA
Generic
62559042007•ANI Pharmaceuticals, Inc.
$0.0974
per ML
MESALAMINE 4 GM/60 ML ENEMA
Generic
21922004549•Encube Ethicals, Inc.
$0.1789
per ML
MESALAMINE 4 GM/60 ML ENEMA
Generic
45802009828•Padagis Israel Pharmaceuticals Ltd
$0.1789
per ML
SULFASALAZINE 500 MG TABLET
Generic
00093323401•Teva Pharmaceuticals USA Inc.
$0.2003
per EA
SULFASALAZINE 500 MG TABLET
Generic
00093323405•Teva Pharmaceuticals USA Inc.
$0.2003
per EA
SULFASALAZINE 500 MG TABLET
Generic
00093323410•Teva Pharmaceuticals USA Inc.
$0.2003
per EA
SULFASALAZINE 500 MG TABLET
Generic
11534020001•Sunrise Pharmaceutical Inc.
$0.2003
per EA
SULFASALAZINE 500 MG TABLET
Generic
11534020004•Sunrise Pharmaceutical Inc.
$0.2003
per EA

Frequently asked questions

What is the NADAC price of MESALAMINE ER 0.375 GRAM CAP?

The current National Average Drug Acquisition Cost (NADAC) for MESALAMINE ER 0.375 GRAM CAP, manufactured by Mylan Pharmaceuticals Inc., is $0.4865 per EA (NDC 00378137578), effective Aug 19, 2026.

How has the price of MESALAMINE ER 0.375 GRAM CAP changed over time?

Over the history we have for it, the NADAC for MESALAMINE ER 0.375 GRAM CAP has declined 83.5%. It has been tracked across 340 weekly CMS publications since Feb 19, 2020.

What are the highest and lowest recorded NADAC prices for MESALAMINE ER 0.375 GRAM CAP?

Since Feb 19, 2020, the NADAC for MESALAMINE ER 0.375 GRAM CAP has ranged from a low of $0.4196 (Feb 18, 2026) to a high of $3.1530 (Aug 12, 2020), with a median of $0.8904 per EA.

Are there cheaper alternatives to MESALAMINE ER 0.375 GRAM CAP?

No other NADAC-published product currently shares the active ingredient and strength of MESALAMINE ER 0.375 GRAM CAP in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures MESALAMINE ER 0.375 GRAM CAP?

MESALAMINE ER 0.375 GRAM CAP (NDC 00378137578) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.